Paolo has over 18 years of experience in the pharmaceutical and CRO industry across Statistics and Data Services. He bought CROS NT in 2003 and has grown the business by adding offices in Germany, the UK and the USA. Paolo is a Professor of Statistics at Bologna University. He is a council member at EFSPI (European Federation of Statisticians in the Pharmaceutical Industry). Paolo is the CEO of PM Holding, a group of Life Sciences companies which includes CROS NT.
In 2014, Andrew took over the role of CEO for CROS NT after 2 years of serving as Vice President in which he was responsible for some of CROS NT’s biggest milestones including business expansion through acquisitions in both the UK and the USA. Andrew began his working life with the Royal Air Force before making the move to the clinical trials business where he has over 18 years of experience. With a strong background in programming and data management, Andrew has worked in Senior Management and Director roles with multiple CROs in Europe and in the USA. He has studied business administration at Walden University, holds an MBA from Newcastle University, and is currently studying law at the Open University.
Giorgio brings over 25 years of experience in the pharmaceutical industry to this role with 20 years spent in the CRO sector covering key roles such as European Financial Controller, Finance and HR Director, and CFO. He is a Chartered Management Accountant and a Chartered Member of the Institute of Personnel and Development
Fabio brings over 25 years of experience in the pharmaceutical industry to CROS NT, having extensive experience with large pharmaceutical and biotechnology companies in Clinical Development, Medical Affairs and Market Access roles. Fabio covered the role of Scientist and Clinical Research Physician and Regional Medical Affairs Manager for the oncology division at Amgen followed by the Nephrology Therapeutic Area Leader & Development Operation Manager. He also maintained important roles in large pharmaceutical companies including Onco-Haematology Medical Director for Roche, Corporate Medical Director and Market Access for Zambon Group and Medical Director at Alexion Pharmaceuticals. Fabio holds a Medical Degree (MD) and an MBA from Bocconi University in Milan.
Paul joined CROS NT in 2012 as Chief Operations Officer. He carries over 22 years of experience in biometrics team management with particular expertise in Clinical Data Management procedures and processes. Most of Paul’s career was spent in large pharmaceutical companies managing functional teams in Data Management, Statistics, Statistical Programming and Medical Writing where he recruited the necessary resources and developed metrics and resource planning for clinical studies. Paul also has experience in leading operations in the CRO sector prior to joining CROS NT and has earned a reputation for quickly developing productive, cohesive and motivated teams. Paul has a degree in Microbiology from the University of Surrey. He is based in the United Kingdom.
Gianni holds the position of Head of Finance, Administration and Human Resources for CROS NT and its affiliates. Prior to joining CROS NT, Gianni served on the Board of Directors for several companies and has worked as a financial consultant. He also has experience in several Research and Selection companies. He has an EMBA (Executive Master in Business Administration) from Alma Graduate School in the Business School of Bologna University
Chris Hamilton joined CROS NT in 2012 after 10 years of working in the pharmaceutical / clinical trial sector. Chris determines and implements the sales and marketing strategy to help ensure the growth for CROS NT. His areas of expertise are consultative customer care, strategic corporate development and the management of international sales and marketing teams. His experience spans pharmaceutical, CRO and publishing companies. Chris holds a B.A. from Trinity College Dublin and a diploma in Strategic Planning and Change Management from the Irish Management Institute.
Mark has served in progressive management positions in the clinical trials industry for over 24 years. He began his clinical research career in the CRO environment as a programmer and project manager and served in project management, business development, and information technology functions. Mark was Project Director for several NDA submissions and global clinical trials, and he has served as department head of data management, clinical operations, and business development groups as well as Director, eClinical Technologies for a major CRO. In addition, Mark occupied the role of CEO of StatWorks, Inc., a data and biometrics focused CRO, for over 8 years. In his most recent role before joining CROS NT, Mark was a Managing Partner and head of sales and marketing for Veracity Logic. He holds an MBA from the Kenan-Flagler School of Business at UNC-Chapel Hill and a BA from the College of William and Mary in Virginia.
Jo became the Country Manager for CROS NT Ltd. upon the acquisition of MDSL International in 2013. As the Managing Director of this biometrics CRO, she ran all aspects of the company from finance and administration to clinical operations and now provides leadership for the CROS UK affiliate. She has gained a considerable amount of experience in managing biometrics for all phases of drug development as well as a wide range of therapeutic areas with particular expertise in Women’s Health, Ophthalmology and Endocrinology. Jo began her career in the pharmaceutical industry in 1997 as a Data Manager after completing a Master’s degree in Clinical Data Management from Kingston University in the UK.
Andrea stepped into the role of Country Manager for CROS NT SrL in 2014 after being a Project Manager for CROS NT since 2011 when he joined the company. In his role as Project Manager, he managed a variety of projects in various therapeutic areas and was responsible for meeting timelines and budget requirements for key clients. As engineer by background, Andrea began his career in 2007 in the Industrial Automation industry as a hardware engineer and then worked as a consultant in the manufacturing industry. He has a degree in Engineering from Brescia University in Italy and an Executive Master’s degree in both Project Management and Business Administration. Andrea has Project Management Professional (PMP) certification.